17th Mar 2009 17:03
Ark Therapeutics Group plc
17 March 2009
Notification of Major Interests in Shares
1 Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
ARK THERAPEUTICS GROUP PLC
2. Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights: (x)
An acquisition or disposal of financial instruments which may
result in the acquisition of shares already issued to which voting
rights are attached ( )
An event changing the breakdown of voting rights: ( )
Other ( )
3. Full name of person(s) subject to the notification obligation:
Barclays PLC
4. Full name of shareholder(s) (if different from 3):
Not notified
5. Date of the transaction and date on which the threshold is crossed or reached if different:
13 March 2009
6. Date on which issuer notified:
17 March 2009
7. Threshold(s) that is/are crossed or reached:
5% to below notifiable %
8. Notified details:
A: Voting rights attached to shares
Class/type of shares: GB0034251727
Situation previous to the triggering transaction:
Number of shares: 12,051,770
Number of voting rights: 12,051,770
Resulting situation after the triggering transaction:
Number of shares: Not reportable
Number of voting rights:
Direct: Not reportable
Indirect: Not reportable
% of voting rights:
Direct: Not reportable
Indirect: Not reportable
B: Financial Instruments:
Resulting situation after the triggering transaction:
Type of financial instrument:
Expiration date:
Exercise/conversion period/date:
Number of voting rights that may be acquired if the instrument is exercised/ converted:
% of voting rights:
Total (A+B):
Number of voting rights: Not reportable
% of voting rights: Not reportable
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
Not notified
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name:
Geoff Smith
15. Contact telephone number:
0207 116 2913
16. Contact name and telephone at issuer:
MARTYN WILLIAMS
Company Secretary, Ark Therapeutics Group plc
020 7388 7722
Related Shares:
PVG.LBarclays